# Masitinib in Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST)

> **NCT00998751** · PHASE2 · COMPLETED · sponsor: **AB Science** · enrollment: 30 (actual)

## Conditions studied

- Gastro-intestinal Stromal Tumours

## Interventions

- **DRUG:** oral masitinib

## Key facts

- **NCT ID:** NCT00998751
- **Lead sponsor:** AB Science
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00998751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00998751, "Masitinib in Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST)". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00998751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*